https://web.archive.org/web/20240924124652/https://edition.cnn.com/2024/09/20/business/23andme-board-resigns-nightcap/index.html

23andme postorder DNA profiling is slowly collapsing. CEO wants to take it private, and board has resigned in protest. This is one of the corps that went public using a SPAC to capitalise on the height of hype. Founded 2006, SPAC in 2021. Revenue is down, and money should run out soon. Seems there's no business model on top of the 1 time purchase of a DNA test. Key asset obv is the data, so I think we can wait for it to be sold to whoever bids most.

Can't wait to see this!